hema.to
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $7.6M
Investors
- 9
About hema.to
to GmbH provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data.to GmbH provides a Cytometry platform to assist diagnosticians in assessing blood cancer and other immune diseases from immune data (flow cytometry or immunophenotyping) by uploading the files on the system to improve the system by using its cloud-based machine learning platform to personalize the analysis and bring precision diagnostics to immune medicine.
Who invested in hema.to
9 investors across 2 rounds
See all investors in hema.to
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about hema.to
Who invested in hema.to?
hema.to has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has hema.to raised?
hema.to has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did hema.to last raise money?
hema.to's most recent round on record is a Seed, in Feb 2025.
What does hema.to do?
to GmbH provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data.
Where is hema.to headquartered?
hema.to is headquartered in Munich, Germany.
Which VCs invest in companies like hema.to?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at hema.to's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like hema.to? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.